The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.
- Resource Type
- Article
- Source
- Vaccines; Feb2023, Vol. 11 Issue 2, p286, 14p
- Subject
NEGATIVE regulatory factor IMMUNE response TOLL-like receptors T cells MESSENGER RNA - Language
- ISSN
- 2076393X